pillbase.ru

Sifrol

Active substance: pramipexole

pramipexole

Centralised EU authorisationActive

Marketing holder: Boehringer Ingelheim International GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 137
  • PRAMIPEXOLE
    TABLET · PRAMIPEXOLE DIHYDROCHLORIDE 1.5 mg/1
    31722-911
    Camber Pharmaceuticals, Inc.
  • PRAMIPEXOLE
    TABLET · PRAMIPEXOLE DIHYDROCHLORIDE .25 mg/1
    31722-907
    Camber Pharmaceuticals, Inc.
  • PRAMIPEXOLE
    TABLET · PRAMIPEXOLE DIHYDROCHLORIDE .125 mg/1
    31722-906
    Camber Pharmaceuticals, Inc.
  • PRAMIPEXOLE
    TABLET · PRAMIPEXOLE DIHYDROCHLORIDE .75 mg/1
    31722-909
    Camber Pharmaceuticals, Inc.
  • PRAMIPEXOLE
    TABLET · PRAMIPEXOLE DIHYDROCHLORIDE .5 mg/1
    31722-908
    Camber Pharmaceuticals, Inc.
All products in this country (137)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-48a9-75be-85f1-2d9c63860547,01a1208c-4ad5-773f-8881-65d9f19912fc,01a1208c-5075-7b58-a3d8-18d2529991a7,01a1208c-622e-7259-bea6-42d0d01c890c,01a1208c-6273-72f7-88e9-4d1dab690adc;count=137 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000133
Registration status
Active
ATC code
N04BC05
Sources
  • product · EMA · EMEA/H/C/000133 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000133 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000133 · Verified 2026-10-09